Company Filing History:
1 out of 8 
1 out of 64 Years Active: 2022
Title: Tadao Maeda: Innovator in Ocular Solutions
Introduction
Tadao Maeda is a notable inventor based in Kobe, Japan. He has made significant contributions to the field of ocular health through his innovative inventions. His work focuses on improving the survival rates of retinal pigment epithelium (RPE) cells, which are crucial for eye health.
Latest Patents
Tadao Maeda holds a patent for a transplantation medium that enhances the post-thawing survival rate of cryopreserved RPE cells. This invention involves suspending RPE cells in a pharmaceutically acceptable medium that acts as an ocular irrigating and washing solution, containing a poloxamer. The patent aims to improve the photoreceptor cell protection effect by RPE cells transplanted immediately after thawing and to prevent the loss of RPE cells during various steps from thawing to transplantation.
Career Highlights
Throughout his career, Tadao Maeda has worked with prominent companies in the pharmaceutical and biotechnology sectors. Notable among these are Healios K.K. and Sumitomo Pharma Co., Ltd. His experience in these organizations has contributed to his expertise in ocular solutions and cell transplantation technologies.
Collaborations
One of Tadao Maeda's notable collaborators is Dai Otagiri. Their partnership has likely fostered advancements in the field of ocular health and cell therapy.
Conclusion
Tadao Maeda's innovative work in the development of transplantation mediums for RPE cells showcases his commitment to enhancing ocular health. His contributions are vital for future advancements in eye care and cell therapy.